Sakae Asanuma - Net Worth and Insider Trading

Sakae Asanuma Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sakae Asanuma owns 1 companies in total, including Werewolf Therapeutics Inc (HOWL) .

Click here to see the complete history of Sakae Asanuma’s form 4 insider trades.

Insider Ownership Summary of Sakae Asanuma

Ticker Comapny Transaction Date Type of Owner
HOWL Werewolf Therapeutics Inc 2021-04-29 director & 10 percent owner

Sakae Asanuma Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sakae Asanuma Ownership Network

Ownership Network List of Sakae Asanuma

No Data

Ownership Network Relation of Sakae Asanuma

Insider Network Chart

Sakae Asanuma Owned Company Details

What does Werewolf Therapeutics Inc do?

Who are the key executives at Werewolf Therapeutics Inc?

Sakae Asanuma is the director & 10 percent owner of Werewolf Therapeutics Inc. Other key executives at Werewolf Therapeutics Inc include director & 10 percent owner Ra Capital Healthcare Fund Lp , Chief Technology Officer Chulani Karunatilake , and Chief Operating Officer Reid Leonard .

Werewolf Therapeutics Inc (HOWL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Werewolf Therapeutics Inc (HOWL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Werewolf Therapeutics Inc (HOWL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Werewolf Therapeutics Inc (HOWL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Werewolf Therapeutics Inc Insider Transactions

No Available Data

Sakae Asanuma Mailing Address

Above is the net worth, insider trading, and ownership report for Sakae Asanuma. You might contact Sakae Asanuma via mailing address: 1030 Massachusetts Avenue, Suite 210, Cambridge Ma 02138.

Discussions on Sakae Asanuma

No discussions yet.